Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Clin Transplant. 2018 Mar 3;32(4):e13215. doi: 10.1111/ctr.13215

Table 2.

Recipient and Donor Characteristics, Stratified by Discharge Timing and Scheduled Follow-Up from the Initial Transplant Admission

Monday–Thursday
N=294
Friday
N=65
Weekend
N=109
Pa Follow Up in ≤2 days
N=99
3–6 days
N=153
7+ days
N=67
Missing
N=149
Pb
Recipient Characteristics
Age at Transplant (Years) 58 (48, 64) 56 (46, 63) 54 (46, 62) 0.23 54 (46, 64) 59 (48, 64) 57 (51, 62) 57 (47, 62) 0.23
Black Race 139 (47%) 36 (55%) 168 (47%) 0.34 48 (48%) 76 (50%) 30 (45%) 69 (46%) 0.90
Male Sex 201 (68%) 37 (57%) 69 (63%) 0.18 67 (68%) 97 (63%) 43 (64%) 100 (67%) 0.87
Dialysis Vintage (Years) 0.32 0.005
0 36 (12%) 7 (11%) 8 (7%) 6 (6%) 28 (18%) 6 (9%) 11 (7%)
<1 year 24 (8%) 5 (8%) 9 (8%) 8 (8%) 15 (10%) 8 (12%) 7 (5%)
>=1 and <3 years 42 (14%) 14 (22%) 26 (24%) 20 (20%) 28 (18%) 14 (21%) 20 (13%)
>=3 years 192 (65%) 39 (60%) 66 (61%) 65 (66%) 82 (54%) 39 (58%) 111 (74%)
Hepatitis C 19 (6%) 4 (6%) 8 (7%) 0.86 7 (7%) 10 (7%) 4 (6%) 10 (7%) 0.62
HIV 8 (3%) 3 (5%) 5 (5%) 0.78 6 (6%) 1 (1%) 1 (1%) 8 (5%) 0.11
Diabetes 107 (36%) 24 (37%) 42 (39%) 0.93 38 (38%) 61 (40%) 23 (34%) 51 (34%) 0.73
Hypertension 278 (95%) 64 (98%) 104 (95%) 0.40 92 (93%) 146 (95%) 61 (91%) 147 (99%) 0.05
CAD 52 (18%) 9 (14%) 19 (17%) 0.81 19 (19%) 17 (11%) 9 (13%) 35 (23%) 0.14
Primary Insurance Type 0.76 0.16
Medicaid & Medicare 208 (71%) 43 (66%) 77 (71%) 70 (71%) 100 (65%) 44 (66%) 114 (77%)
Private Insurance 86 (29%) 22 (34%) 32 (29%) 29 (29%) 53 (35%) 23 (34%) 35 (23%)
BMI (kg/m2) 28 (24, 32) 30 (25, 33) 29 (26, 32) 0.13 29 (25, 33) 28 (24, 32) 28 (25, 31) 28 (25, 33) 0.67
Donor/Allograft Characteristics
Donor Age (Years) 46 (30, 54) 38 (26, 55) 44 (28, 54) 0.31 43 (31, 54) 44 (27, 53) 49 (30, 55) 48 (29, 54) 0.43
Donor Race 0.76 0.002
White 202 (69%) 43 (66%) 80 (73%) 60 (61%) 116 (76%) 42 (63%) 107 (72%)
Black 46 (16%) 12 (18%) 18 (17%) 19 (19%) 19 (12%) 19 (28%) 19 (13%)
Asian 9 (3%) 3 (5%) 1 (1%) 1 (1%) 3 (2%) 3 (4%) 6 (4%)
Unknown 36 (12%) 7 (11%) 9 (8%) 18 (18%) 14 (9%) 3 (4%) 17 (11%)
Donor Male Sex 175 (60%) 35 (58%) 73 (67%) 0.35 66 (67%) 83 (54%) 42 (63%) 95 (64%) 0.19
KDPI 54 (31, 73) 54 (33, 74) 51 (32, 74) 0.36 47 (27, 68) 52 (27, 72) 62 (39, 76) 55 (36, 74) 0.31
Delayed Graft Function 122 (41%) 28 (43%) 30 (28%) 0.03 37 (37%) 65 (42%) 27 (40%) 51 (34%) 0.51
DCDD 56 (19%) 12 (18%) 22 (20%) 0.95 16 (16%) 24 (16%) 15 (22%) 35 (23%) 0.26
Cold Ischemia Time (Hours) 15 (12, 21) 16 (12, 19) 14 (11, 23) 0.98 15 (12, 18) 14 (11, 18) 15 (11, 21) 16 (13, 22) 0.02
Discharge Condition
NODAT 36 (12%) 7 (11%) 15 (14%) 0.36 11 (11%) 21 (14%) 9 (13%) 17 (11%) 0.90
Length of Stay > 4 Days 143 (49%) 25 (38%) 38 (35%) 0.03 41 (41%) 57 (37%) 32 (48%) 76 (51%) 0.09
Discharge on Dialysis 48 (16%) 12 (18%) 17 (16%) 0.88 14 (14%) 30 (20%) 10 (15%) 23 (15%) 0.63
Discharge on Insulin 114 (42%) 27 (42%) 48 (44%) 0.92 41 (43%) 72 (49%) 27 (40%) 49 (36%) 0.14

Abbreviations: HIV—Human Immunodeficiency Virus; CAD—Coronary Artery Disease (defined as history of myocardial infarction, coronary bypass, or angioplasty/stent); BMI—Body Mass Index; k—kilograms; m—meters; KDPI—Kidney Donor Profile Index; DCDD—Donation after Circulatory Determination of Death; NODAT—New Onset Diabetes after Transplantation

a

—Comparing weekday and weekend discharge

b

—Comparing durations to outpatient follow-up